Safety and tolerability of single and multiple ascending doses of lunsekimig (SAR443765) in healthy participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509316-28-00

Acronym

SAD18184/MAD18185

Enrollment

128

Registered

2024-04-18

Start date

2024-05-06

Completion date

2024-12-24

Last updated

2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026